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Objectives: Synthetic cannabinoid or “Bonzai” use is a public health issue as its use has increased in
Turkey as well as all over the world. The aim of this study is to evaluate the effectiveness of the “Synthetic
Cannabinoids Seminar” that was provided to physicians who work in emergency services, using multiple
choice questionnaires before and after the seminar as a tool for evaluation.
Material and method: Synthetic cannabinoids seminars were provided to physicians who work in
emergency services in two different cities, with the participation of 20 physicians in each scheduled
seminar. The seminars were instructed by emergency medicine specialists and psychiatrists who were
certiﬁed as an instructor by the Turkish Ministry of Health, after receiving an instructor course in syn-
thetic cannabinoids. In order to measure basal knowledge levels of the participants, a pretest was per-
formed for all participants before the seminar. After the seminar, a posttest was performed using the
same questions in the pretest. The number of correct answers in both tests was then compared.
Results: In total, 85 individuals attended the seminars; 29 individuals from Dumlupınar University Evliya
Çelebi Training and Research Hospital constituted ﬁrst group, and 56 individuals from Denizli State
Hospital constituted second group. In both groups, the ratios of correct answers in the posttest were
determined to be higher when compared to the pretest.
Conclusion: The seminars on synthetic cannabinoids are useful and necessary for physicians.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
For centuries, cannabinoids have been used as pleasure-
inducing substances. As there are a growing number of worri-
some reports taking place in themedia, Bonzai use threatens public
health at an alarming rate. Bonzai is a synthetic drug created via the
addition of chemical compounds to various dried and decomposed
plants. Synthetic cannabinoids (SCs) are tetrahydrocarbon-like
naphtholindoles. The SC JWH-018 molecule, which is also called
Bonzai, was developed at the Clemson University Organic Chem-
istry Laboratory in 1995, by Professor John W. Huffman.1
In Turkey, JWH-018 molecule is sold in packages that have
“bonzai” written on them, hence the given name. In Europe, it is
known as “spice”, and in America it is known as “K2”. Owing to the
recently increased production of SCs and the lower cost of their.
ncy Medicine Association of
e Association of Turkey. Production
ons.org/licenses/by-nc-nd/4.0/).distribution, SC use has increased. SCs known as “Bonzai, Jamaican,
Spice, Spicegold, Spicesilver, Yutacan Fire, K2” in the market can
easily be obtained.2,3 Especially recently, SC use has increased
among adolescents and young adults.4 One study from the US in
2011 reported that 11% of high school students used marijuana
(cannabis) or SCs during the last 12 months.5 Some of the reasons
why SCs are so popular are that they are known to have cannabis-
like properties, they can be obtained easily, they are inexpensive
and they can not be detected in routine drug screening tests.3 In
2009, European countries started to ban and control the use of SCs,
with Austria and Germany being the ﬁrst.6,7 In Turkey, it had been
used extensively until the Council of Ministers decided on 7 January
2011 to add it to the list of substances that are subject to the Law on
Control of Narcotic Drugs, with issue number 2011/1310.8
In December 2014, a total of 165 physicians, consisting of
emergency medicine specialists and psychiatrists, received an in-
structor's course on SCs that was given by the Turkish Ministry of
Health. This instructor course was given by Turkey's Public Hospi-
tals Institution Health Facilities Emergency Health Services Head of
Department, academic personnel in Emergency Medicine andand hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
Table 1
Test questions.
1 What is the chemical code of “Bonzai”, which is a synthetic cannabinoid?
2 Which is not required to call a person an addict?
3 Which is not an appropriate approach to a patient who uses narcotic drugs?
4 Which of the following ﬁndings is less likely in cannabinoid use?
5 Which of the following parameters has less importance in examination of synthetic cannabinoid use?
6 Which is not regarded as normal during observation of patient using synthetic cannabinoid?
7 Which would be your ﬁrst option in an agitated patient due to synthetic cannabinoid use?
8 Which would be your ﬁrst option in a patient with tachycardia due to synthetic cannabinoid use?
9 Which is not expected in a patient with prolonged agitation who has been physically restricted?
10 For which patients who use synthetic cannabinoid, admission to hospital is generally not necessary?
11 Which is not a purpose of supervised release?
12 Do you feel competent in treating a patient exposed to synthetic cannabinoid, considering your present knowledge?
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personnel experienced in Forensic Medicine.
The course included topics on the history of SCs, their chemical
actions, areas of use, and treatment and forensic aspects after
exposure. In order to achieve a standard for instructors throughout
the country, the training material that they are supposed to use
during the seminars was given to them. After this course, the at-
tendants were titled as a “Synthetic Cannabinoid Instructor”, and
seminars were scheduled throughout the country. On the sched-
uled day, these seminars were provided to general practitioners
and emergencymedicine specialists working in emergency services
in all cities of Turkey.
The aim of our study is to examine the effectiveness of the
seminars given by Ministry of Health on knowledge levels of the
physicians working in emergency services, and to evaluate physi-
cians' knowledge levels after attending the seminars.2. Material and method
As an exclusion criteria, we determined to exclude the partici-
pants who were reluctant but non of the physicians refused to
participate the study.
In Dumlupınar University Evliya Çelebi Training and Research
Hospital and in Denizli State Hospital, the seminars were led by two
instructors (an emergency medicine specialist and a psychiatrist).
In order to measure basal knowledge levels of attendants on the
seminar topic, a “pretest” was performed that was composed of 12
questions. Participants were advised not to interact during this
pretest. During the seminars which lasted for 60 minutes, the
instructor emergency medicine specialists lectured using 48 slides.
The same test was repeated at the end of the seminar, again while
preventing interaction between participants.
In order to determine the effectiveness of the seminars, a test
consisting of 12 questions was performed as a pretest and posttest
to the attending physicians in two different cities (Table 1). TestsTable 2
Ratio of correct answers at pretest and posttest in both groups.
Q1: What is the chemical code of “Bonzai”, which is a synthetic cannabinoid?
Q2: Which is not required to call a person an addict?
Q3: Which is not an appropriate approach to a patient who uses narcotic drugs?
Q4: Which of the following ﬁndings is less likely in cannabinoid use?
Q5: Which of the following parameters has less importance in examination of synthet
Q6: Which is not regarded as normal during observation of patient using synthetic ca
Q7: Which would be your ﬁrst option in an agitated patient due to synthetic cannabin
Q8: Which would be your ﬁrst option in a patient with tachycardia due to synthetic c
Q9: Which is not expected in a patient with prolonged agitation who has been physic
Q10: For which patients who use synthetic cannabinoid, admission to hospital is gene
Q11: Which is not a purpose of supervised release?consisted of multiple-choice questions, and were prepared based
on the training materials provided by the Ministry of Health.
Time allowed for the pretest and posttest was 20 minutes.
Physicians in the seminars were prevented from interacting with
each other while answering the questions. Demographical data
such as age and sex of the participant physicians was obtained
during the pretest. Before the study, all attending physicians were
informed that their scores would not be shared with other partic-
ipants, their names were not required, and that the purpose of the
test was to determine the effectiveness of the seminar.
The software package SPSS for Windows version 16.0 was used
for statistical analysis. The data are presented as mean, standard
deviation (SD) and percentiles. Percentiles were rounded to the
closest whole number.
3. Results
The study group was comprised of 85 physicians. There were 29
physicians from Dumlupınar University Evliya Çelebi Training and
Research Hospital and 56 physicians from Denizli State Hospital.
Mean age of the whole group was 34.9 ± 8.7 years (min. 25, max. 63
years old), with 58 (68.2%) male and 27 (31.8%) female.
The ratios of correct answers at pretest and posttest are pre-
sented in Table 2.
In both pretest and posttest, participants were asked whether
they felt competent in treating a patient exposed to SC, considering
their present knowledge, in the 12th question. In the pretest, this
questionwas answered as “yes” by 11 (12.9%) participants, whereas
this number increased up to 79 (92.9%) participants after the
seminar (Table 3).
4. Discussion
In this study, physicians working in emergency services were
tested for their knowledge before and after attending a seminar on
SCs, and it was observed that the seminars were successful overall.Pretest Posttest
67.9% 98.8%
38.8% 81.2%
77.6% 92.9%
28.2% 50.6%
ic cannabinoid use? 70.2% 90.6%
nnabinoid? 53.0% 89.4%
oid use? 31.8% 90.6%
annabinoid use? 34.1% 95.3%
ally restricted? 55.3% 89.4%
rally not necessary? 97.6% 98.8%
57.1% 71.4%
Table 3
Ratio of the physicians who answered “yes” to the question “Do you feel competent in treating a patient exposed to synthetic cannabinoid, considering your present
knowledge?”
Pretest Posttest
Do you feel competent in treating a patient exposed to synthetic cannabinoid, considering your present knowledge?” 12.9% 92.9%
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Control Centers (AAPCC), the number of exposures to SCs in 2009
was 53, whereas in 2011 this number was 13,000.9 In their study,
Wood et al determined the number of SC exposures was 14 in 2009,
2821 in 2010 and 6255 in 2011, and they stated that the number in
2012 was even greater than in 2011.10 As SC use grows, related
admissions to emergency departments also increase. SC use is
especially increasing among adolescents and young adults.4
Vandrey et al aimed to study out the characteristic properties of
SC abused patients in an internet-based study with the participa-
tion of 168 people. Respondents were primarily male, Caucasian
and 12 years of education. Use of other psychoactive drugs was
common, though 21% identiﬁed Spice products as their preferred
drug.11
In a study, Kuçuk et al examined demographical data of 112
patients who presented directly to emergency departments during
a sixmonth period between 01.02.2014 and 31.07.2014 due to use of
SCs called Bonzai or Jamaica; they reported that 111 patients were
male and only one patient was female. Mean age of the patients
was 23.32 ± 6.14 years. Sixty-one patients (55.46%) were dis-
charged after being evaluated in the emergency department, 27
patients (24.10%) were treated in the intensive care unit, 15 patients
(13.39%) left the emergency department after refusing treatment or
without notice, and 9 patients (8.03%) were admitted to the inter-
nal medicine ward.12 Discharge rates from emergency departments
are low, and admission rates to intensive care units are high; this
could be due to physicians' insufﬁcient knowledge on SCs. Their
knowledge levels can be increased with training.
Aksel et al reported that 190 of the 197 patients over the age of
18, who presented to the emergency department of training and
research hospital during two years' time were male, with four pa-
tients being hospitalized and two patients dying. Both patients who
died were male, and they were intubated on presentation due to
low GCS. Of the remaining patients, 52 were discharged of their
own will, and 141 patients were discharged after inspection for
6e12 h. Mean age of the presenting patients was 22 (19e27) years.
Mean systolic blood pressure was 120 (110e126) mmHg, mean
diastolic blood pressure was 70 (62e80) mmHg, and mean pulse
rate was 89 (78e105) bpm.13
In 2013, Lank et al prepared a self-administered internet-based
survey, to which 73 emergency physicians attended. 72% of the
attendees reported that they are informed via non-medical sources
about SCs,17% of themwere unaware of these drugs' marijuana-like
effects, and 25% of them did not know SCs are synthetic drugs.
Nearly 80% of the physicians do not feel qualiﬁed enough in treating
a patient intoxicatedwith SCs. According to the results of this study,
emergency physicians are very unfamiliar with SCs, thus most of
them need additional training.14
Urazel et al in 2015, applied a questionnaire to 100 physicians
(42% research assistants, 29% expert physicians and 29% practi-
tioners) who work in emergency department, to assess the
knowledge of the physicians on SCs. Questions were about general
information on these drugs. As a result of this research it was re-
ported that it is essential to improve the physicians' knowledge
about these substances, as their use is rapidly increasing day by
day.15In our study, we observed that the Turkish Ministry of Health's
seminars on SCs that were provided to physicians working in
emergency services in two different cities were effective.5. Limitations
This study is limited by its small sample size that may not
represent all the physicians in Turkey, as well as in the world. Also,
the seminars were provided by different instructors that may lead
unstandardized education despite the standard educational
material.6. Conclusion
There's an increasing use of SCs in Turkey and all over the
world.1 Physicians often fail to follow the development rate of these
drugs, their effects, chemical structures and treatment. Emergency
physicians should have a continuous education on these
substances.References
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